Talk:Moclobemide
From Wikipedia, the free encyclopedia
 |
Moclobemide is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome. |
| B | This article has been rated as B-Class on the quality scale. |
| Mid | This article has been rated as mid-importance for this Project's importance scale. |
|
|
|
Contents |
[edit] Taking with other antidepressants
The statement that Moclobemide should not be taken concurrently with other antidepressants is not correct: it is now prescribed in combination with a tricyclic such as amitryptiline or dothiepin, often with the tricyclic at its maximum dose. This prescribing plan is used by Profs. Paykel and Cowen of Cambridge and Oxford Universities respectively, presumably amongst others. I don't know about using it with other types of antidepressant, though, so presumably caution should still be exercised. Chris 21:24, 26 June 2006 (UTC)
- Thanks for updating the main page, Outriggr. Chris 09:36, 27 June 2006 (UTC)
- I have used in concurrently with reboxetine, amongst other things. There is potentiation, but that is to be expected.
- The warning is based on the fact that MAO-A-inhibition can cause potentially fatal reactions to drugs that elevate serotonin, and that NE/DA drugs can be potentiated 4-8 times (IIRC).
- Similarly, EpiPens are potentiated, etc. Zuiram 18:54, 24 November 2006 (UTC)
Good results have also been obtained with SSRI combinations (I'm currently having good results myself). See for example Moclobemide and Specific Serotonin Re-uptake Inhibitor Combination Treatment of Resistant Anxiety and Depressive Disorders (Bakish et al. 1994). Certainly there is a strong synergy, so doses are necessarily much lower, but much of the previously assumed risk is based on the established danger of combining non-reversible MAOs moclobemide. I'm too inexpert, pressed for time, and crap with wiki citation to incorporate any of this information 131.172.4.44 (talk) 01:51, 7 April 2008 (UTC)snaxalotl
[edit] MDMA
Someone should add on the possible lethal/quite dangerous interaction with MDMA.
- Any MAOI will have a potentially lethal interaction with MDMA ;)
- Moclobemide doesn't have less potential for interaction than the traditional MAOIs, it just has less dietary restrictions, and a less complicated metabolism. Zuiram 18:55, 24 November 2006 (UTC)
[edit] Dietary restrictions
Like much of this article, the section on dietary restrictions is wrong; I'll put it on my TODO list, and see if I can get around to fixing it eventually.
At a the recommended maximum dose of 600mg day, the TYR30 is about 150mg, which is why that dose was chosen as the highest recommended dose: it's virtually impossible for a person with a normal diet to consume enough tyramine in a single sitting to cause a dangerous reaction at that dose.
At higher doses, regular tyramine restrictions should be adhered to, and the drug has been in clinical use up to 1200mg/day.
Even at the lower doses, you should avoid yeast extracts like Bovril and Marmite, as these are a fairly reliable way to get a dangerous tyramine dose in a single serving.
[edit] Standard MAOIs comparison
The following text:
- Unlike standard MAOIs, possible side effects do not include cardiovascular complications (hypertension) with encephalopathy, liver toxicity or hyperthermia.
Is a bit misleading. First off, hepatotoxicity and such complications are linked to the older MAOIs that are no longer in use. Of the current generation, only Nardil carries any significant potential for hepatotoxicity. Hypertension and hyperthermia are related to dietary and drug interactions, and remain an issue with moclobemide, although it will take more of the offending substance to cause it with typical doses of moclobemide. And someone should elaborate on what kind of encephalopathy they feel is common with the unselective MAOIs. Zuiram 19:04, 24 November 2006 (UTC)
